
Qloudlab
closedThe first connected and modular medical device for mobile diagnostic.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $5.9m | Early VC | |
Total Funding | 000k |
EUR | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 1 % | (8 %) | 4 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Qloudlab SA was a medical technology company established in 2012 and officially registered in October 2013, which has since transitioned to operate as Loop Medical SA. The firm was founded by Arthur Queval, who brought to the venture a background in microengineering and bioengineering from the Swiss Institute of Technology (EPFL) and McGill University. Prior to founding Qloudlab, Queval gained experience as an Innovation Project Manager at Swatch Group Ltd. and is the inventor or co-inventor of over 40 international patents. The company initially focused on developing a Point-of-Care diagnostic platform, securing 1.5 million CHF in private funding.
The company's primary objective evolved to the development and marketing of on-site diagnostic medical devices, biosensors, and blood collection technologies. This has culminated in the creation of a needle-free, painless blood collection technology designed for ease of use by both healthcare professionals and patients at home. The technology aims to simplify the blood testing process, making it less stressful and more accessible. The company has developed two main products under the names 'Onflow' and 'Maxflow', which are capable of collecting different volumes of blood (up to 1.5ml and 4ml, respectively) in minutes. These devices are engineered to be compatible with existing medical laboratory analysis workflows.
The business operates in the medical device and diagnostics market, targeting a wide range of clients from individual patients to healthcare organizations. Its business model centers on the sale of these proprietary blood collection devices. The company has undergone several name changes and restructuring, officially operating as Loop Medical SA since early 2019. It continues to pursue its vision of making blood diagnostics universally accessible and has received support from various organizations. Loop Medical's products are currently available for investigational use only as it seeks market approval.
Keywords: point-of-care diagnostics, blood collection technology, medical devices, biosensors, biochemistry, painless blood draw, needle-free, home diagnostics, Onflow, Maxflow, Arthur Queval, Loop Medical, in-vitro diagnostics, diagnostic platform, microengineering, bioengineering, medical technology, remote patient monitoring, diagnostic testing